Navigation Links
Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

Results Reported From Three NCI-Sponsored Clinical Trials

SOUTH SAN FRANCISCO, CA June 28, 2007 - Cytokinetics, Incorporated (Nasdaq: CYTK) announced results from the analyses of three Phase II clinical trials of ispinesib administered as monotherapy, one in patients with hepatocellular cancer, one in patients with melanoma, and one in patients with hormone-refractory prostate cancer. Ispinesib is a novel small molecule inhibitor of kinesin spindle protein (KSP), a mitotic kinesin essential for proper cell division. Ispinesib has arisen from a broad strategic collaboration between Cytokinetics and GlaxoSmithKline (GSK) to discover, develop and commercialize novel small molecule therapeutics targeting human mitotic kinesins for applications in the treatment of cancer and other diseases. All three clinical trials were sponsored by the National Cancer Institute (NCI).

A Phase II clinical trial designed to evaluate the safety and efficacy of ispinesib in the treatment of patients with locally advanced, recurrent or metastatic hepatocellular cancer was recently completed. In Stage 1 of this two-stage clinical trial, 15 patients received ispinesib as monotherapy at 18 mg/m2 as a 1-hour intravenous infusion every 21 days. The trial s primary endpoint was objective response as determined using the Response Evaluation Criteria in Solid Tumors (RECIST) criteria. This trial was designed to require at least 1 confirmed partial or complete response out of 15 evaluable patients in Stage 1 in order to proceed to Stage 2. The best overall response was stable disease seen in 7 of the 15 patients treated. In this clinical trial, ispinesib did not satisfy the criteria for advancement to the second stage and therefore recruitment to Stage 2 was not opened. The toxicity profile was consistent with other previously reported Phase II clinical trials of ispinesib. A manuscript is being prepared.

A Phase
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:5/28/2015)... Calif. , May 28, 2015  Based ... market, Frost & Sullivan recognizes Lexmark Healthcare ... Sullivan Award for Company of the Year in ... take HCM to the next level of interoperability ... acquisitions and followed them up with large-scale product ...
(Date:5/28/2015)... , May 26, 2015 Research ... of the "2015 Strategies in the US ... Market" report to their offering. ... provides comprehensive analysis of the diagnostic testing markets ... ICUs). The report includes analysis of the market ...
(Date:5/28/2015)... -- Cypher Genomics, Inc., the leading genome ... announced a collaboration in which Cypher,s automated genomic interpretation ... genetic diseases among a unique population. Located in ... Children (CSC) serves many Amish and Mennonite patients, a ... disease. "We are very excited to ...
Breaking Medicine Technology:Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 3Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 4Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 5Strategies in the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market 2015-2020 2Cypher Genomics and Clinic for Special Children Collaborate on Rare Disease Study 2Cypher Genomics and Clinic for Special Children Collaborate on Rare Disease Study 3
... -- BERGISCH GLADBACH, Germany, September 22, 2010 ... ... ... Results are keyed by longUrl, so we need to grab the first one. for (var r in ...
... With a company rank on this year,s list ... list of companies who have surpassed expectations during ... (Logo: http://photos.prnewswire.com/prnh/20100817/INC5000LOGO ) (Logo: ... List honors the fastest growing private companies in ...
Cached Medicine Technology:Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 2Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 3Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 4Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 5Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 6
(Date:5/28/2015)... San Francisco,CA (PRWEB) May 28, 2015 ... to creating technology that advances sexual health and ... that the University of San Francisco (USF) will ... online college sexual assault recording and reporting system. ... more empowering, transparent, and confidential reporting experience for ...
(Date:5/28/2015)... May 28, 2015 lifeIMAGE ... round of financing led by Cambia Health Solutions ... dedicated to transforming health care by creating a person-focused ... most utilized network for exchanging medical imaging, will use ... base, increase the breadth of its network capabilities and ...
(Date:5/28/2015)... Optimity Advisors ( Optimity ) ... of care for healthcare organizations worldwide – today ... help operationalize contracting and engagement models. As part ... series of seven “ OrangePapers” that provide ... is a strategy, operations and information technology advisory ...
(Date:5/28/2015)... 28, 2015 WebWatcher, the ... their partnership with BeSure Consulting to help ... The partnership will combine BeSure Consulting’s ... parental monitoring software solution. , Led by ... Consulting's passion is concentrated on teaching law ...
(Date:5/28/2015)... Cancer survivors who participated in the LIVESTRONG ... fitness and quality of life, according to research conducted ... Jennifer Ligibel, MD, senior physician in the Susan F. ... The findings will be presented at this year’s ... in Chicago. , The study, designed to ...
Breaking Medicine News(10 mins):Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2Health News:WebWatcher Partners with BeSure Consulting 2Health News:WebWatcher Partners with BeSure Consulting 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4
... Nov. 3 The Guardian Life Insurance Company ... benefit enrollment,services by adding more features to serve ... Census Bureau, Spanish speakers constitute 12,percent of the ... has introduced customized Spanish-language benefit enrollment,kits, with everything ...
... Genoveva (“Gigi”) Garcia, a 91-year-old movie buff who once was a ... final reel in her life has a surprising twist: Her granddaughter, ... sharing her riches-to-rags-to-riches story with others on CarePages.com, a community of ... , ...
... 3 Paul Offit, MD,announced today that all author ... False Prophets: Bad Science, Risky Medicine, and the Search,for ... Autism Research at,Children,s Hospital of Philadelphia., (Photo: ... with Dr. Offit, and to accept the,royalties of his ...
... scientists have discovered a mechanism by which intracellular pathogens ... weapons against them: nitric oxide. The researchers found that ... biochemical machinery used by immune cells called macrophages to ... tanks of the immune system, attacking and consuming bacteria ...
... in detecting airway stent complications according to a recent ... Harvard Medical School in Boston, MA. , MDCT ... patients, including all cases of intraluminal narrowing, migration, invasion ... of four cases of stent fracture," according to Vandana ...
... or surgical procedures for children with suspected musculoskeletal ... study performed at Vanderbilt Children,s Hospital in Nashville, ... on 130 children with suspected musculoskeletal infections; 34 ... after diagnostic or therapeutic intervention and 96 patients ...
Cached Medicine News:Health News:Guardian Enhances Enrollment Capabilities With More Spanish Language Services 2Health News: Jennifer & Gigi: A Story of Love and Compassion with a Hollywood Twist -- In honor of National Family Caregivers Month, CarePages.com celebrates "Grandma Gene" and gives a voice to the community of caregivers around the world 2Health News: Jennifer & Gigi: A Story of Love and Compassion with a Hollywood Twist -- In honor of National Family Caregivers Month, CarePages.com celebrates "Grandma Gene" and gives a voice to the community of caregivers around the world 3Health News:Author Royalties From Autism Book Donated to Autism Research 2Health News:Parasites that live inside cells use loophole to thwart immune system 2Health News:Parasites that live inside cells use loophole to thwart immune system 3
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light....
This single lamp light source is perfect for surgeon's offices, cath labs, dermatology offices, and specialty uses....
Delivers one primary lamp and one backup lamp. The port accepts ACMI fiberoptic cables....
The 300W effective dual light source has quality xenon performance....
Medicine Products: